The board of directors of Eli Lilly and Company has declared a dividend for the second quarter of 2024 of $1.30 per share on outstanding common stock. The dividend is payable on June 10, 2024, to shareholders of record at the close of business on May 16, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
807.9 USD | +0.05% | +0.58% | +38.59% |
May. 28 | Annual sales of weight-loss drugs seen hitting $150 billion | RE |
May. 28 | Weight-loss drug forecasts jump to $150 billion as supply grows | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.47% | 238B | |
+7.35% | 204B | |
-6.42% | 203B | |
+4.23% | 161B | |
-1.70% | 160B | |
-1.31% | 120B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Eli Lilly and Company Declares Dividend for the Second Quarter of 2024, Payable on June 10, 2024